SCHEMBL474250

SCHEMBL474250

NCCP(c1ccccc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
HTR2A P28223 4/20 0.40
TAAR1 Q96RJ0 3/20 0.40
LOXL2 Q9Y4K0 2/20 0.40
CYP2A6 P11509 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HRH1 P35367 2/20 0.37
MAOA P21397 1/20 0.36
KIF11 P52732 4/20 0.33
CYP1A2 P05177 3/20 0.33
CYP2D6 P10635 2/20 0.33
CYP2C19 P33261 2/20 0.33
TSHR P16473 2/20 0.32
CYP2C9 P11712 1/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
TRPM2 O94759 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29192763 0.97 CYP3A4 (0.39) CYP3A4TDP1HTR2ATAAR1LOXL2
Hydrochloric Acid SCHEMBL29241928 0.97 CYP3A4 (0.39) CYP3A4TDP1HTR2ATAAR1LOXL2
SCHEMBL27633570 0.97 CYP3A4 (0.39) CYP3A4TDP1HTR2ATAAR1LOXL2
SCHEMBL27351171 0.97 CYP3A4 (0.39) CYP3A4TDP1HTR2ATAAR1LOXL2
SCHEMBL28479254 0.97 CYP3A4 (0.39) CYP3A4TDP1HTR2ATAAR1LOXL2
SCHEMBL16053155 0.95 CYP3A4 (0.38) CYP3A4TDP1HTR2ATAAR1LOXL2
SCHEMBL31568158 0.91 CYP3A4 (0.35) CYP3A4TDP1HTR2ATAAR1LOXL2
SCHEMBL28145951 0.91 CYP3A4 (0.35) CYP3A4TDP1HTR2ATAAR1LOXL2
SCHEMBL1466232 0.91 CYP3A4 (0.35) CYP3A4TDP1HTR2ATAAR1LOXL2
SCHEMBL1767611 0.91 CYP3A4 (0.35) CYP3A4TDP1HTR2ATAAR1LOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 574 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250122269-A1 SELECTIVE REDUCTION OF ANTIBODIES ABBVIE INC (US) 2025-04-17 US claimed
CN-119752477-A Oil-gas well demulsifier 滨州乾坤化工机械有限公司 2025-04-04 CN claimed
CN-119488608-A Engineering bispecific antibody coupling drug and preparation method and application thereof 上海药明合联生物技术有限公司 2025-02-21 CN claimed
CN-119213022-A Preparation method of antibody-drug conjugate 上海迈晋生物医药科技有限公司 2024-12-27 CN claimed
CN-119050391-A Platinum-copper alloy catalyst for improving particle durability and preparation method and application thereof 无锡威孚高科技集团股份有限公司 2024-11-29 CN claimed
CN-117838879-B Preparation method for improving homogeneity of antibody-drug conjugate and application thereof 上海药明合联生物技术有限公司 2024-11-01 CN claimed
CN-118724689-A Method for preparing glycolaldehyde by bridged catalytic formylating formaldehyde 天津大学 2024-10-01 CN claimed
US-20240295038-A1 METAL-IMPREGNATED CARBON MATERIALS UNITED STATES DEPARTMENT OF ENERGY 2024-09-05 US claimed
CN-118440445-A Modified plastic master batch and preparation method thereof 安徽九牛塑业科技有限公司 2024-08-06 CN claimed
CN-117720537-B Axial chiral indole-furan catalyst and preparation method and application thereof 江苏师范大学 2024-07-09 CN claimed
EP-2759555-A1 Processes for the preparation of rheoloy modifiers Elementis Specialties, Inc. (US) 2014-07-30 EP claimed
US-20140135468-A1 PROCESSES FOR THE PREPARATION OF RHEOLOGY MODIFIERS ELEMENTIS SPECIALTIES, INC. 2014-05-15 US claimed
CN-101367892-B Method for preparing functionalized polymers BRIDGESTONE CORP 2014-01-29 CN claimed
CN-103254331-A Process for producing functionalized polymers BRIDGESTONE CORP 2013-08-21 CN claimed
US-20120235315-A1 METHOD FOR FABRICATING A FLEXIBLE DEVICE ETERNAL CHEMICAL CO., LTD. 2012-09-20 US claimed
CN-101367892-A Method for preparing functionalized polymers BRIDGESTONE CORP (JP) 2009-02-18 CN claimed
US-7271121-B2 Diimine metal complexes, methods of synthesis, and methods of using in oligomerization and polymerization CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2007-09-18 US claimed
EP-1206427-B1 CHIRAL LIGANDS, TRANSITION-METAL COMPLEXES THEREOF AND USES THEREOF IN ASYMMETRIC REACTIONS PENN STATE RES FOUND (US) 2005-11-09 EP claimed
CN-1686979-A Cross couple method for synthesizing compound of liquid crystal by 2-2 phenyl palladium phosphine ethylamine catalysis UNIV DALIAN TECH (CN) 2005-10-26 CN claimed
US-6380392-B1 COMPLEXES THE PENN STATE RESEARCH FOUNDATION 2002-04-30 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250122269-A1 SELECTIVE REDUCTION OF ANTIBODIES CD2BP2, CD22, CD2 CYP3A4 3960/4885TDP1 2072/4885HTR2A 2349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.